Diogo Martins-Branco is an expert in Oncology at Institut Jules Bordet (Belgium). Diogo Martins-Branco has authored 66 publications, the most recent in 2026. SLR score: 264 (community average: 125). How the SLR is computed.

LeadR Profile

Diogo Martins-Branco Institut Jules Bordet Belgium
264 ScienceLeadR Reputation 264
Network Map

Oncology

Subspecialties: Public Health - Biochemistry - Radiotherapy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2013 - 2026

Source: PubMed

Institut Jules Bordet

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 66

Citations

Citations: 360 1st author: 16 Last author: 0 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Long-term outcomes and treatment response in early-stage invasive lobular carcinoma: insights from a nationwide population-based study.
PMID 42284621 — mortality, breast neoplasms, neoplasms, breast, neoadjuvant therapy, therapeutics, carcinoma, lobular, prognosis
ESMO Open20260
Long-term immune response to mRNA anti-SARS-CoV-2 vaccination in patients with cancer.
PMID 42245650 — cells, sars-cov-2, vaccines, neoplasms, adaptive immunity, rna, messenger, vaccination, covid-19, immune system diseases, immunity, therapeutics, severe acute respiratory syndrome-related coronavirus, b-lymphocytes, infections
Front Immunol20260
Emotional Daily Life Library (E-DLL): Validation of a database of 3D objects for emotion elicitation.
PMID 42205355 — emotions, perception, signs and symptoms, arousal
Int J Clin Health Psychol20260
Mind-wandering facilitates creative performance in a musical improvisation task.
PMID 41933521 — consciousness, creativity, cognition
Conscious Cogn20260
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with EGFR, ALK, or BRAF/MEK inhibitors.
PMID 41759225 — radiotherapy, safety, pharmaceutical preparations, neoplasms
ESMO Open20260

LeadR Networks

Main global connection map